🔗 Share this article

Chancellor Rachel Reeves has stated she is planning "targeted measures to address cost of living challenges" in next month's Budget.

In comments to media outlets, she emphasized that lowering inflation is a collective duty of both the government and the central bank.

The UK's price growth is expected to be the most elevated among the G7 developed nations this calendar year and the following year.

Potential Energy Cost Measures

Sources suggest the government could intervene to bring down energy bills, for example by reducing the present 5% rate of VAT charged on energy supplies.

An additional option is to reduce some of the policy costs currently added to household expenses.

Fiscal Limitations and Expert Expectations

The administration will receive the next report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these measures.

The view from most economists is that the Chancellor will have to announce tax rises or budget cuts in order to fulfill her declared borrowing rules.

Previously on Thursday, estimates indicated there was a twenty-two billion pound deficit for the Treasury chief to address, which is at the lower end of projections.

"It is a joint job between the Bank of England and the administration to continue tackling some of the drivers of price increases," the Chancellor told the BBC in the US capital, at the yearly gatherings of the IMF and global financial institution.

Tax Commitments and International Issues

While a great deal of the attention has been on likely tax rises, the chancellor said the latest figures from the OBR had not changed her vow to election pledges not to increase tax levels on income tax, sales tax or social security contributions.

She blamed an "unpredictable global environment" with rising geopolitical and commercial tensions for the fiscal tax moves, probably to be focused on those "wealthiest."

Global Economic Tensions

Referring to worries about the United Kingdom's commercial links with the Asian nation she said: "The UK's security interests always are paramount."

Recent statement by China to tighten export controls on rare earths and other resources that are essential for advanced tech manufacturing led US President Donald Trump to propose an additional 100% import tax on imports from China, increasing the prospect of an full-scale trade war between the two largest economies.

The American finance chief described the Chinese decision "commercial pressure" and "a international production power grab."

Questioned on accepting the US offer to participate in its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese actions and called on the Chinese government "not to put up barriers and restrict access."

She said the action was "damaging for the international commerce and causes additional headwinds."

"It is my opinion there are areas where we should challenge China, but there are also valuable chances to sell into China's economy, including financial services and other sectors of the economic system. We've got to maintain that balance appropriate."

The chancellor also confirmed she was working with international partners "on our own critical minerals plan, so that we are more independent."

Health Service Drug Pricing and Investment

Reeves also acknowledged that the cost the National Health Service pays for medicines could rise as a result of ongoing discussions with the US government and its drugs companies, in return for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or canceling investments in the United Kingdom, with some attributing the low prices they are receiving.

Last month, the government science advisor said the price the NHS pays for drugs would need to rise to prevent firms and drug research funding leaving the United Kingdom.

Reeves told media: "It has been observed due to the pricing regime, that medical research, recent pharmaceuticals have not been provided in the UK in the extent that they are in other continental states."

"Our aim is to ensure that individuals receiving care from the NHS are can receive the finest essential treatments in the world. And so we are reviewing all of that, and... aiming to secure increased funding into Britain."